Analysts' ratings for ResMed (NYSE:RMD) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 2 | 1 | 0 | 0 |
| Last 30D | 0 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 2 | 1 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
Analysts have set 12-month price targets for ResMed, revealing an average target of $222.33, a high estimate of $238.00, and a low estimate of $200.00. Surpassing the previous average price target of $215.67, the current average has increased by 3.09%.
Deciphering Analyst Ratings: An In-Depth Analysis
The analysis of recent analyst actions...
Login or create a forever free account to read this news
Sign up/Log in